New cocktail of drugs shows promise against tough gut cancers
NCT ID NCT05329766
First seen Oct 31, 2025 · Last updated May 23, 2026 · Updated 26 times
Summary
This study tests whether combining new drugs with or without standard chemotherapy can help people with advanced stomach, gastroesophageal junction, or esophageal cancer. About 332 participants will receive different treatment combinations to see if they shrink tumors and improve survival. The goal is to find safer and more effective ways to control these hard-to-treat cancers.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTROINTESTINAL TRACT MALIGNANCIES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Research Site
Phoenix, Arizona, 85054, United States
-
Research Site
Los Angeles, California, 90033, United States
-
Research Site
Santa Monica, California, 90024, United States
-
Research Site
Derby, Connecticut, 06418, United States
-
Research Site
Fort Myers, Florida, 33901, United States
-
Research Site
Jacksonville, Florida, 32224, United States
-
Research Site
St. Petersburg, Florida, 33705, United States
-
Research Site
Boston, Massachusetts, 02109, United States
-
Research Site
New York, New York, 10021-0005, United States
-
Research Site
New York, New York, 10032, United States
-
Research Site
Durham, North Carolina, 27710, United States
-
Research Site
Columbus, Ohio, 43219, United States
-
Research Site
Oklahoma City, Oklahoma, 73104, United States
-
Research Site
Nashville, Tennessee, 37203, United States
-
Research Site
Nashville, Tennessee, 37232, United States
-
Research Site
Fairfax, Virginia, 22031, United States
-
Research Site
Toronto, Canada
-
Research Site
Las Condes, Chile
-
Research Site
Recoleta, Chile
-
Research Site
Santiago, Chile
-
Research Site
Talca, Chile
-
Research Site
Bordeaux, France
-
Research Site
Brest, France
-
Research Site
Caen, France
-
Research Site
Lille, France
-
Research Site
Lyon, France
-
Research Site
Marseille, France
-
Research Site
Montpellier, France
-
Research Site
Plérin, France
-
Research Site
Poitiers, France
-
Research Site
Rouen, France
-
Research Site
Toulouse, France
-
Research Site
Villejuif, France
-
Research Site
Belgrade, Serbia
-
Research Site
Kamenitz, Serbia
-
Research Site
Kragujevac, Serbia
-
Research Site
Busan, South Korea
-
Research Site
Daegu, South Korea
-
Research Site
Hwasun, South Korea
-
Research Site
Seongnam-si, South Korea
-
Research Site
Seoul, South Korea
-
Research Site
Suwon, South Korea
Conditions
Explore the condition pages connected to this study.